Effectiveness and safety of a narrow band spectrum intense pulsed‐light dye with long pulse Nd:YAG laser for treating facial vascular lesions.

Objective: Different devices are currently used for treating facial vascular lesions (FVL). This paper presents the aesthetic outcomes using different light‐based and laser devices, including narrow band spectrum intense pulsed‐light dye (NB‐Dye‐VL), Pulsed dye laser (PDL)–neodymium‐doped yttrium‐aluminum‐garnet (Nd:YAG) dual‐therapy, and either PDL or LP Nd:YAG for treating FVL in a clinical setting. Methods: A retrospective and single‐center study conducted on subjects ≥18 years with FVL. Patients underwent treatment with either PDL + LP Nd:YAG dual‐therapy, NB‐Dye‐VL, PDL, or LP Nd:YAG, according to the patient and lesion characteristics. The primary outcome was the weighted degree of satisfaction. Results: The cohort consisted of fourteen patients, nine women (64.3%) and five men (35.7%). The most prevalent FVL types treated were rosacea (28.6%; 4/14) and spider hemangioma (21.4%; 3/14). Seven patients underwent PDL + Nd:YAG (50.0%), three were treated with NB‐Dye‐VL (21.4%), and PDL or LP Nd:YAG was performed in two patients each (14.3%). Eleven patients rated their treatment outcome as excellent (78.6%), and three as very good (21.4%). Practitioners 1 and 2 classified treatment results as excellent in eight cases (57.1%) each. No serious or permanent adverse events were reported. Two (14.3%) patients, one treated with PDL and the other with PDL + LP Nd:YAG dual‐therapy, had post‐treatment purpura, which was successfully resolved with topical treatment after 5 and 7 days, respectively. Conclusions: NB‐Dye‐VL and the PDL + LP Nd:YAG dual‐therapy devices achieve excellent aesthetic outcomes for treating a wide range of FVL. [ABSTRACT FROM AUTHOR]